Literature DB >> 31321654

Left atrial appendage orifice diameter measured with trans-esophageal echocardiography is independently related with peri-device leakage after Watchman device implantation.

Yu-Yi Chen1,2, Yong-Hua Zhang1, Xin Chen1, Wei-Ping Huang1, Bei Xu1, Xi Su3,4, Yan-Hong Chen5.   

Abstract

Percutaneous left atrial appendage closure (LAAC) has emerged as an alternative of stroke prevention in non-valvular atrial fibrillation (NVAF) patients. Peri-device leakage after LAAC is common. This retrospective, case-control study aimed to identify risk factors related with peri-device leakage after LAAC with Watchman devices. Patients who underwent Watchman devices implantation received trans-esophageal echocardiography (TEE) before, during and 45 days after procedure. Peri-device leakage was defined as a residual flow of any size detected with TEE. Patients with residual flows were compared with sex and age matched controls without leakage after implantation. Basic clinical characteristics, as well as LAA imaging characteristics were collected and compared. From 2014 to 2016, 125 consecutive patients were implanted with Watchman devices in our center. TEE at 45 days after implantation identified 53 patients with peri-device leakages (2.62 ± 1.55 mm), who were compared with 43 sex and age matched controls who also received the Watchman devices implantation and had no peri-device residual flow. The basic clinical characteristics, as well as LAA morphology were comparable between the two groups, while patients with leakages had larger LAA orifice, longer LAA body and larger LAA volume. Multivariate logistic regression analysis showed that LAA orifice size measured with TEE was the only independent risk factor predicting post-procedural leakage. The AUC of the receiver operating characteristic (ROC) curve was 0.70. Using the TEE orifice size cutoff value of 18.7 mm yielded a sensitivity of 0.92 (specificity 0.52), while the cutoff value of 23.1 mm yielded a high specificity of 0.91 (sensitivity 0.24). Minor peri-device leakage ( < 5 mm) is common after LAAC with Watchman devices. LAA orifice diameter measured with TEE is the independent risk factor predicting peri-device leakage after the implantation.

Entities:  

Keywords:  Incomplete closure; Left atrial appendage closure; Left atrial appendage morphology; Residual flow; Watchman device

Mesh:

Year:  2019        PMID: 31321654     DOI: 10.1007/s10554-019-01625-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  26 in total

1.  Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke.

Authors:  Juan F Viles-Gonzalez; Vivek Y Reddy; Jan Petru; Tomas Mraz; Zuzana Grossova; Stepan Kralovec; Petr Neuzil
Journal:  J Interv Card Electrophysiol       Date:  2011-09-21       Impact factor: 1.900

2.  The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.

Authors:  Juan F Viles-Gonzalez; Saibal Kar; Pamela Douglas; Srinivas Dukkipati; Ted Feldman; Rodney Horton; David Holmes; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2012-03-06       Impact factor: 24.094

Review 3.  EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion.

Authors:  Bernhard Meier; Yuri Blaauw; Ahmed A Khattab; Torsten Lewalter; Horst Sievert; Claudio Tondo; Michael Glikson
Journal:  EuroIntervention       Date:  2015-01       Impact factor: 6.534

4.  Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation.

Authors:  Yutao Guo; Yingchun Tian; Hao Wang; Quanjin Si; Yutang Wang; Gregory Y H Lip
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

5.  Post-Approval U.S. Experience With Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.

Authors:  Vivek Y Reddy; Douglas N Gibson; Saibal Kar; William O'Neill; Shephal K Doshi; Rodney P Horton; Maurice Buchbinder; Nicole T Gordon; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2016-11-02       Impact factor: 24.094

6.  Left atrial appendage morphology: comparison of transesophageal images and postmortem casts.

Authors:  C Stöllberger; G Ernst; E Bonner; J Finsterer; J Slany
Journal:  Z Kardiol       Date:  2003-04

7.  Multimodality imaging in preoperative assessment of left atrial appendage transcatheter occlusion with the Amplatzer Cardiac Plug.

Authors:  Alberto Clemente; Francesco Avogliero; Sergio Berti; Umberto Paradossi; Giuli Jamagidze; Marco Rezzaghi; Daniele Della Latta; Dante Chiappino
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-04-27       Impact factor: 6.875

8.  Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.

Authors:  Staffan Björck; Bo Palaszewski; Leif Friberg; Lennart Bergfeldt
Journal:  Stroke       Date:  2013-08-27       Impact factor: 7.914

9.  Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study.

Authors:  M F Stoddard; P R Dawkins; C R Prince; N M Ammash
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

10.  Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.

Authors:  Moti Haim; Moshe Hoshen; Orna Reges; Yardena Rabi; Ran Balicer; Morton Leibowitz
Journal:  J Am Heart Assoc       Date:  2015-01-21       Impact factor: 5.501

View more
  2 in total

1.  Changes in left atrial appendage orifice following percutaneous left atrial appendage closure using three-dimensional echocardiography.

Authors:  Xochitl A Ortiz-Leon; Edith L Posada-Martinez; Alda Bregasi; Wanwen Chen; Ian Crandall; Jason Pereira; Kamil F Faridi; Joseph G Akar; Ben A Lin; Robert L McNamara; James V Freeman; Jeptha Curtis; Jose A Arias-Godinez; Lissa Sugeng
Journal:  Int J Cardiovasc Imaging       Date:  2022-01-22       Impact factor: 2.357

2.  Thermally responsive hydrogel for atrial fibrillation related stroke prevention.

Authors:  Troy Hendrickson; Cristina Lupo; Guillermo Bauza; Liliana Tavares; Shannon Ingram; Sufen Wang; Michael Moreno; Ennio Tasciotti; Miguel Valderrabano; Francesca Taraballi
Journal:  Mater Today Bio       Date:  2022-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.